Literature DB >> 13304781

Acute leukaemia in adults treated with 6-mercaptopurine.

D M WHITELAW, R G MOFFAT, W H PERRY, R E BECK.   

Abstract

Entities:  

Keywords:  LEUKEMIA/therapy; PURINES/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13304781      PMCID： PMC1823193     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Treatment of leukaemia and allied disorders with 6-mercaptopurine.

Authors:  J R FOUNTAIN
Journal:  Br Med J       Date:  1955-05-07

2.  Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases.

Authors:  J H BURCHENAL; M L MURPHY; R R ELLISON; M P SYKES; T C TAN; L A LEONE; D A KARNOFSKY; L F CRAVER; H W DARGEON; C P RHOADS
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

3.  Evaluation of 6-mercaptopurine in the treatment of leukemia; a preliminary report.

Authors:  B E HALL; M D RICHARDS; F M WILLETT; T V FEICHTMEIR; P M AGGELER
Journal:  Stanford Med Bull       Date:  1953-11

4.  Clinical evaluation of 6-mercaptopurine in the treatment of leukemia.

Authors:  J H BURCHENAL; D A KARNOFSKY; M L MURPHY; R R ELLISON; M P SYKES; C T TAN; A C MERMANN; M YUCEOGLU; C P RHOADS
Journal:  Am J Med Sci       Date:  1954-10       Impact factor: 2.378
  4 in total
  3 in total

1.  Vincaleukoblastine in the treatment of malignant disease.

Authors:  D M WHITELAW; J M TEASDALE
Journal:  Can Med Assoc J       Date:  1961-09-02       Impact factor: 8.262

2.  Lymphoblastic aleukaemic leukaemia with bone changes in an adult.

Authors:  T A Michael; B Parvaresh; G Galoostian; C Z Bidari
Journal:  Postgrad Med J       Date:  1966-08       Impact factor: 2.401

3.  Therapy of acute leukaemia: comparison of initial treatment with 6-mercap-topurine alone and in combination with steroids.

Authors:  J M BRIDGES; D M HAYES; M G NELSON
Journal:  Br J Cancer       Date:  1962-03       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.